These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6304498)

  • 1. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.
    Whitlock CA; Ziegler SF; Witte ON
    Mol Cell Biol; 1983 Apr; 3(4):596-604. PubMed ID: 6304498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.
    Whitlock CA; Witte ON
    J Virol; 1981 Nov; 40(2):577-84. PubMed ID: 6275106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS; Liang Y; Reedstrom CK; Wu SQ
    Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
    Green PL; Kaehler DA; Risser R
    J Virol; 1987 Jul; 61(7):2192-7. PubMed ID: 3035219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity.
    Reynolds FH; Van de Ven WJ; Stephenson JR
    J Virol; 1980 Nov; 36(2):374-86. PubMed ID: 6253663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.
    Palumbo GJ; Ozanne BW; Kettman JR
    Cancer Res; 1990 Mar; 50(6):1917-23. PubMed ID: 2155061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
    Rosenberg NE; Clark DR; Witte ON
    J Virol; 1980 Dec; 36(3):766-74. PubMed ID: 6257926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular biology of Abelson virus transformation.
    Witte ON
    Curr Top Microbiol Immunol; 1983; 103():127-46. PubMed ID: 6303708
    [No Abstract]   [Full Text] [Related]  

  • 9. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of virus--cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells.
    Whitlock CA; Witte ON
    Adv Immunol; 1985; 37():73-98. PubMed ID: 2988306
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism.
    Cook WD; Metcalf D; Nicola NA; Burgess AW; Walker F
    Cell; 1985 Jul; 41(3):677-83. PubMed ID: 2988782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abelson leukemia virus.
    Rosenberg N
    Curr Top Microbiol Immunol; 1982; 101():95-126. PubMed ID: 6303705
    [No Abstract]   [Full Text] [Related]  

  • 13. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
    Rotter V; Witte ON; Coffman R; Baltimore D
    J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abelson murine leukemia virus variants with increased oncogenic potential.
    Murtagh K; Skladany G; Hoag J; Rosenberg N
    J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.
    Pierce JH; Di Fiore PP; Aaronson SA; Potter M; Pumphrey J; Scott A; Ihle JN
    Cell; 1985 Jul; 41(3):685-93. PubMed ID: 2988783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
    Thome KC; Radfar A; Rosenberg N
    J Virol; 1997 Nov; 71(11):8149-56. PubMed ID: 9343165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
    Dyall-Smith D; Cory S
    Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some lymphoid cell lines transformed by Abelson murine leukemia virus lack a major 36,000-dalton tyrosine protein kinase substrate.
    Sefton BM; Hunter T; Cooper JA
    Mol Cell Biol; 1983 Jan; 3(1):56-63. PubMed ID: 6298608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.